Adaptive Biotechnologies Corp (NASDAQ:ADPT) shares, rose in value on Wednesday, March 26, with the stock price down by -2.14% to the previous day’s close as strong demand from buyers drove the stock to $8.24.
Actively observing the price movement in the last trading, the stock closed the session at $8.42, falling within a range of $8.15 and $8.5369. The value of beta (5-year monthly) was 1.532. Referring to stock’s 52-week performance, its high was $9.01, and the low was $2.28. On the whole, ADPT has fluctuated by -2.14% over the past month.
With the market capitalization of Adaptive Biotechnologies Corp currently standing at about $1.22 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-10.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 212.69M, with a low estimate of 39.8M and a high estimate of 44.81M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 42.13M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ADPT’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of ADPT currently trading nearly 5.68% and 5.47% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 55.51, while the 7-day volatility ratio is showing 6.57% which for the 30-day chart, stands at 9.49%. Furthermore, Adaptive Biotechnologies Corp (ADPT)’s beta value is 1.71, and its average true range (ATR) is 0.65.
A comparison of Adaptive Biotechnologies Corp (ADPT) with its peers suggests the former has fared considerably weaker in the market. ADPT showed an intraday change of -2.14% in last session, and over the past year, it grew by 154.32%%.
Data on historical trading for Adaptive Biotechnologies Corp (NASDAQ:ADPT) indicates that the trading volumes over the past 10 days have averaged 2.04 and over the past 3 months, they’ve averaged 1.70 million. According to company’s latest data on outstanding shares, there are 147.77 million shares outstanding.
Nearly 4.61% of Adaptive Biotechnologies Corp’s shares belong to company insiders and institutional investors own 92.59% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 9.49 million shares as on 2025-03-14, resulting in a short ratio of 4.82. According to the data, the short interest in Adaptive Biotechnologies Corp (ADPT) stood at 818.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 8.78 million. The stock has risen by 37.45% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ADPT stock heading into the next quarter.
